Skip to main content
Cencora, Inc.
Healthcare · Medical Distribution
Made on Aug 19, 2026
Price at call $316.32
6-month call Bull +5.3%
Target by Feb 2027 $333.00
Great value below $275.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +5.3% to $333.00
Predicted High $333.00 at 6 months
Predicted Low $312.00 at 1 month
Max Drawdown (predicted) -1.4%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 19, 2026 12:21 pm
Bull COR trends higher to $333.00 (+5.3% from $316.32) by Feb 2027. dip-then-recover
ThesisCOR is a low-beta distributor trading below signal-adjusted fair value with a bruised sentiment tape but improving quality signals. Path is a slow grind higher toward the deterministic baseline as the May miss fades and value gravity dominates over months, with modest near-term chop given weak sentiment.
Invalidated ifA break below $290 on volume or a negative pre-announcement would falsify the recovery thesis
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $316.32 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 19, 2026 $316.32 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 2, 2026 $298.93–$333.71 typical range · internal point $314.50 ±5.5% 6/10 Sentiment drag lingers, low beta caps moves
1 month Sep 19, 2026 $291.12–$341.52 typical range · internal point $312.00 ±8.0% 5/10 Quiet tape, mild drift below current
2 months Oct 19, 2026 $318.00 +0.5% 5/10 Stabilization as May miss ages out
3 months Nov 19, 2026 $324.00 +2.4% 5/10 Value gravity pulls toward fair value band
4 months Dec 19, 2026 $328.00 +3.7% 4/10 Year-end positioning favors defensive distributors
5 months Jan 19, 2027 $330.00 +4.3% 4/10 Approach deterministic baseline, DCF support
6 months Feb 19, 2027 $333.00 +5.3% 4/10 Converges near baseline, signal-adjusted anchor above

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $332.28 (+5.0%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$316.32
Composite fair value$292.49
Signal-adjusted fair value$366.70
DCF fair value$377.66
Anchored-PE fair value$277.38
Buy-below (value lens)$275.00
Value net score+5
Value confidence6 / 10
Quality net score+39
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 32.6%  3m 27.6%  6m 37.0%  
Daily σ (realism noise)1.7%
Beta vs S&P 500 1m -0.90  3m -0.63  5m -0.47  
Trailing 6-month return-12.2%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 12, 2026 7d behind COR-20260812-001122-c217
ext-forensic-memo Aug 19, 2026 freshest ext-COR-20260819-121701-9f48
ext-lens-quality Aug 19, 2026 freshest ext-COR-20260819-121701-9f48
ext-lens-sentiment Aug 19, 2026 freshest ext-COR-20260819-121701-9f48
ext-lens-value Aug 19, 2026 freshest ext-COR-20260819-121701-9f48
scenario-valuation Aug 19, 2026 freshest COR-20260812-001122-c217
valuation-synthesis Aug 19, 2026 freshest COR-20260819-001959-56aa

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

1 frozen snapshot — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 19, 2026 v0.6.0 Bull $316.32 $333.00 +5.3% Feb 2027 viewing

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.